Evolving Indications for Active Surveillance in Low-Risk Localized Prostate Cancer

Publisher： Elsevier

ISSN： 1569-9056

Source： European Urology Supplements, Vol.2, Iss.9, 2003-12, pp. : 7-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Percutaneous radiotherapy for low-risk prostate cancer: options for 2007

By Bottke Dirk Wiegel Thomas

World Journal of Urology, Vol. 25, Iss. 1, 2007-03 ,pp. : 53-57

Springer Publishing Company

Access to resources Recommend Favorite

Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study

By Cussenot Olivier Cornu Jean-Nicolas Drouin Sarah Mozer Pierre Egrot Christophe Vaessen Christophe Haab François Bitker Marc-Olivier Rouprêt Morgan

World Journal of Urology, Vol. 32, Iss. 2, 2014-04 ,pp. : 545-550

Springer Publishing Company

Access to resources Recommend Favorite

Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer

By Bolton D. Ta A. Bagnato M. Muller D. Lawrentschuk N. Severi G. Syme R. Giles G.

World Journal of Urology, Vol. 32, Iss. 2, 2014-04 ,pp. : 431-435

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of localized prostate cancer

By Burchardt Martin Huland Hartwig

World Journal of Urology, Vol. 25, Iss. 1, 2007-03 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?

By DeWitt K.D. Sandler H.M. Weinberg V. McLaughlin P.W. Roach M.

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 492-496

Elsevier

Access to resources Recommend Favorite